Dongsung Pharm (002210) — Free Cash Flow Generation Index

Latest as of June 2025: 1.07x

Dongsung Pharm (002210) has a Free Cash Flow Generation Index of 1.07x as of June 2025. Free cash flow of ₩4.50 Billion represents 1% of operating cash flow (₩4.20 Billion). See 002210 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.07x
Free Cash Flow / Operating CF

Free Cash Flow

₩4.50 Billion
KRW

Operating Cash Flow

₩4.20 Billion
KRW

Capital Expenditures

₩0.00
KRW

Dongsung Pharm Free Cash Flow Generation Index (2010–2020)

Historical FCF Generation Index trend for Dongsung Pharm across 4 annual periods. Explore cash flow to debt ratio of Dongsung Pharm to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Dongsung Pharm (2010–2020)

Year-by-year Free Cash Flow Generation Index for Dongsung Pharm. For the full company profile including market capitalisation, see 002210 company net worth.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2020 -0.38x ₩-1.91 Billion ₩5.01 Billion ₩6.92 Billion ▲ +27.5%
2018 -0.53x ₩-733.54 Million ₩1.39 Billion ₩2.13 Billion ▲ +21.4%
2017 -0.67x ₩-1.21 Billion ₩1.80 Billion ₩3.00 Billion ▼ -154.5%
2010 1.23x ₩4.53 Billion ₩3.68 Billion ₩847.33 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).